| 摘要 |
The invention provides compounds of Formula (I): wherein: R<SUP>1</SUP>-R<SUP>5</SUP>, A, L, and X have any of the values defined in the specification that are CCR-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use, and methods and intermediates useful for preparing them.
|
